Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin and Rifabutin Regimens for MAC Lung Disease
NCT00598962Phase 4Completed
- Sponsor
- The University of Texas Health Science Center at Tyler
- Start
- Dec 1994
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of azithromycin in Mycobacterium avium complex lung disease, sponsored by The University of Texas Health Science Center at Tyler. Primary endpoint: Clinical and microbiological outcomes at 6 months. Started Dec 1994; status: completed.
02
Drugs
azithromycin
03
Conditions
Mycobacterium avium complex lung disease
Beyond the preview
Go deeper on NCT00598962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598962.